MicroVention, a privately-held company, was founded in 1997 with the strategic objective of developing and marketing medical devices to enable or significantly improve the treatment of vascular diseases in small vessels. The current focus is on catheter-based products for endovascular treatment of neurovascular diseases, serving the specialty of interventional neuroradiology. The Company’s lead product, the MicroPlex Coil System, is a uniquely designed embolization device for the treatment of cerebral aneurysms. In development is a revolutionary, next-generation device called the HydroCoil Embolization System.